Your browser doesn't support javascript.
loading
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer.
Weng, Weining; Meng, Tao; Zhao, Qianqian; Shen, Yi; Fu, Guoxiang; Shi, Jing; Zhang, Yue; Wang, Zhaohui; Wang, Mingqiao; Pan, Rong; Ma, Linjie; Chen, Caiwei; Wang, Lijun; Zhou, Biao; Zhang, Hui; Pu, Junyi; Zhang, Jianjian; Hu, Yi Peter; Hua, Guoqiang; Qian, Yu; Liu, Shu-Hui; Hu, Wenhao; Meng, Xun.
Afiliación
  • Weng W; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Meng T; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Zhao Q; HySlink Therapeutics, Shanghai, China.
  • Shen Y; MabCare Therapeutics, Shanghai, China.
  • Fu G; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Shi J; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Zhang Y; D1 Medical Technology Company, Shanghai, China.
  • Wang Z; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Wang M; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Pan R; Abmart Inc., Xuhui District, Shanghai, China.
  • Ma L; Abmart Inc., Xuhui District, Shanghai, China.
  • Chen C; Abmart Inc., Xuhui District, Shanghai, China.
  • Wang L; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Zhou B; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Zhang H; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Pu J; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Zhang J; HySlink Therapeutics, Shanghai, China.
  • Hu YP; School of Life Sciences, Northwest University, Xi'an, Shaanxi, China.
  • Hua G; Multitude Therapeutics, Xuhui District, Shanghai, China.
  • Qian Y; D1 Medical Technology Company, Shanghai, China.
  • Liu SH; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
  • Hu W; Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
  • Meng X; Multitude Therapeutics, Xuhui District, Shanghai, China.
Cancer Discov ; 13(4): 950-973, 2023 04 03.
Article en En | MEDLINE | ID: mdl-36693125
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Neoplasias Pulmonares / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Cancer Discov Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Inmunoconjugados / Neoplasias Pulmonares / Antineoplásicos Límite: Animals / Humans Idioma: En Revista: Cancer Discov Año: 2023 Tipo del documento: Article País de afiliación: China